| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sanjay Prakash, Deepali Lodha, Kalu Singh Rawa. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? BMJ case reports. vol 14. issue 8. 2021-08-18. PMID:34400419. |
coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? |
2021-08-18 |
2023-08-13 |
Not clear |
| Nick Kruijt, Luuk Van den Bersselaar, Marc Snoeck, Kees Kramers, Sheila Riazi, Coen Bongers, Susan Treves, Heinz Jungbluth, Nicol Voerman. RYR1-related rhabdomyolysis: a spectrum of hypermetabolic states due to ryanodine receptor dysfunction. Current pharmaceutical design. 2021-08-05. PMID:34348614. |
this review focuses on ryr1-related rhabdomyolysis, in the context of several clinical presentations (i.e., exertional rhabdomyolysis, exertional heat illnesses and mh), and conditions involving a similar hypermetabolic state, in which ryr1 variants may be present (i.e., neuroleptic malignant syndrome and serotonin syndrome). |
2021-08-05 |
2023-08-13 |
Not clear |
| Manuel Pereira Herrera, Aphrodite Marta Zimmerma. Case of refractory delirious mania responsive to lithium. BJPsych open. vol 7. issue 4. 2021-07-20. PMID:34184627. |
more often seen in patients with a history of bipolar disorder, it frequently presents with prominent catatonic features and overlaps with other diseases in the catatonic spectrum, such as neuroleptic malignant syndrome, serotonin syndrome and malignant catatonia. |
2021-07-20 |
2023-08-13 |
Not clear |
| Diana Apetauerova, Pritika A Patel, Joseph D Burns, David P Lerne. Movement Disorder Emergencies. Neurologic clinics. vol 39. issue 2. 2021-06-22. PMID:33896535. |
inadvertent or purposeful overdose of many psychiatric medications can result in acute life-threatening movement disorders including serotonin syndrome, neuroleptic malignant syndrome, and malignant catatonia. |
2021-06-22 |
2023-08-13 |
Not clear |
| Mitsuhito Soh, Toru Hifumi, Shutaro Isokawa, Masato Shimizu, Norio Otani, Shinichi Ishimats. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. The American journal of emergency medicine. vol 43. 2021-06-14. PMID:32622686. |
the authors' response: a diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. |
2021-06-14 |
2023-08-13 |
Not clear |
| Sanjay Prakas. A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome. The American journal of emergency medicine. vol 43. 2021-06-14. PMID:33008703. |
a diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. |
2021-06-14 |
2023-08-13 |
Not clear |
| Christie Sun, Hannah Sweet, Alicia B Minns, Desiree Shapiro, Willough Jenkin. A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Pediatric emergency care. vol 36. issue 10. 2021-05-28. PMID:29698346. |
a mixed presentation of serotonin syndrome vs neuroleptic malignant syndrome in a 12-year-old boy. |
2021-05-28 |
2023-08-13 |
Not clear |
| Christie Sun, Hannah Sweet, Alicia B Minns, Desiree Shapiro, Willough Jenkin. A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Pediatric emergency care. vol 36. issue 10. 2021-05-28. PMID:29698346. |
neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) are serious medical conditions associated with commonly prescribed psychiatric medications. |
2021-05-28 |
2023-08-13 |
Not clear |
| Erica L Holland, Russell P Saneto, Emily K Knippe. Hypermetabolic Syndrome and Dyskinesia After Neurologic Surgery for Labrune Syndrome: A Case Report. A&A practice. vol 14. issue 7. 2021-01-06. PMID:32371820. |
the diagnosis was broadened to include neuroleptic malignant syndrome, serotonin syndrome, and malignant hyperthermia. |
2021-01-06 |
2023-08-13 |
Not clear |
| Cynthia Wright Talto. Serotonin Syndrome/Serotonin Toxicity. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. vol 37. issue 10. 2020-11-03. PMID:33132683. |
this review of serotonin syndrome or serotonin toxicity covers the years 2014 to 2019, including information on pathophysiology, etiology, and diagnosis, 3 criteria for diagnosing serotonin syndrome, and criteria for neuroleptic malignant syndrome. |
2020-11-03 |
2023-08-13 |
Not clear |
| Juan Fernando Ortiz, Martín Wirth, Noha Eskander, Jazmin Carolina Cozar, Olumuyiwa Fatade, Bindu Ratho. The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders? Cureus. vol 12. issue 9. 2020-10-31. PMID:33123448. |
the genetic foundations of serotonin syndrome, neuroleptic malignant syndrome, and malignant hyperthermia: is there a genetic association between these disorders? |
2020-10-31 |
2023-08-13 |
human |
| Juan Fernando Ortiz, Martín Wirth, Noha Eskander, Jazmin Carolina Cozar, Olumuyiwa Fatade, Bindu Ratho. The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders? Cureus. vol 12. issue 9. 2020-10-31. PMID:33123448. |
neuroleptic malignant syndrome (nms), serotonin syndrome (ss), and malignant hyperthermia (mh) share similar clinical characteristics. |
2020-10-31 |
2023-08-13 |
human |
| Petra Truedson, Michael Ott, Evelina Bernberg, Ursula Wernek. [Neuroleptic malignant syndrome and serotonin syndrome - severe adverse reactions with psychotropic medications]. Lakartidningen. vol 117. 2020-10-23. PMID:32940904. |
[neuroleptic malignant syndrome and serotonin syndrome - severe adverse reactions with psychotropic medications]. |
2020-10-23 |
2023-08-13 |
Not clear |
| Petra Truedson, Michael Ott, Evelina Bernberg, Ursula Wernek. [Neuroleptic malignant syndrome and serotonin syndrome - severe adverse reactions with psychotropic medications]. Lakartidningen. vol 117. 2020-10-23. PMID:32940904. |
neuroleptic malignant syndrome and serotonin syndrome are two conditions that can occur with psychotropic medications. |
2020-10-23 |
2023-08-13 |
Not clear |
| Valeriy Zvonare. Takotsubo Cardiomyopathy: Medical and Psychiatric Aspects. Role of Psychotropic Medications in the Treatment of Adults with "Broken Heart" Syndrome. Cureus. vol 11. issue 7. 2020-10-01. PMID:31423403. |
moreover, some cases have been reported in which the development of ttc was associated with the serotonin syndrome, neuroleptic malignant syndrome, and similar fatal consequences. |
2020-10-01 |
2023-08-13 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
olanzapine-associated neuroleptic malignant syndrome: is there an overlap with the serotonin syndrome? |
2020-09-30 |
2023-08-12 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
the possible relationship between neuroleptic malignant syndrome and serotonin syndrome is at present in the focus of scientific interest. |
2020-09-30 |
2023-08-12 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
methods: this retrospective phenomenological study aims to examine the seventeen reported olanzapine - induced neuroleptic malignant syndrome cases under the light of possible overlap between neuroleptic malignant syndrome and serotonin syndrome clinical features. |
2020-09-30 |
2023-08-12 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
results: the serotonin syndrome clinical features most often reported in cases initially diagnosed as neuroleptic malignant syndrome are: fever (82%), mental status changes (82%) and diaphoresis (47%). |
2020-09-30 |
2023-08-12 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
conclusion: the results of this study show that the clinical symptoms of olanzapine-induced neuroleptic malignant syndrome and serotonin syndrome are overlapping suggesting similarities in underlying pathophysiological mechanisms. |
2020-09-30 |
2023-08-12 |
Not clear |